Media Summary: Su-Mien Chong speaks about the timing for working with the Julie Bullock, PharmD, Certara, discusses the limitations the In this webinar, hosted by Zuber Lawler, a panel of industry experts discuss how best to

Interact Face To Face With The U S Fda - Detailed Analysis & Overview

Su-Mien Chong speaks about the timing for working with the Julie Bullock, PharmD, Certara, discusses the limitations the In this webinar, hosted by Zuber Lawler, a panel of industry experts discuss how best to CDER discusses communication best practices when During this webinar the panel of experts will discuss “How to Recapping a year's worth of progress, taking a moment to recognize our amazing staff, and discussing what's next for the

Patients, caregivers and advocates discuss why communities should consider requesting an Su-Mien Chong talks about what external influences play a factor in getting devices approved or cleared through the Kellie Reynolds and Xinning Yang from CDER's Office of Clinical Pharmacology discuss two Advancing the Science of Patient Input in the Regulatory Settings, presented by Martin Ho, Sarah Stothers, Ting-Hsuan Lee, and ...

Photo Gallery

Interact Face to Face with the U.S. FDA
When to Interact with FDA
Building Your Network and Value to Obtain External Input Prior to Interacting with FDA
Teaser Ask the Experts  How to have an effective INTERACT meeting with the FDA
How to communicate with the FDA
Communication Best Practices – Interacting with Regulatory Project Managers in CDER/ORO
USFDA How To Behave in Audit Room?Face #regulatory  #inspection #audits #usfda #gmp #pharma #aseptic
How to Communicate With the FDA
FDA Direct - Special Edition of FDA Direct
First Interaction with the FDA
When a Patient Speaks
FDA Direct: The Power of Real-Time Clinical Trials
Sponsored
Sponsored
View Detailed Profile
Interact Face to Face with the U.S. FDA

Interact Face to Face with the U.S. FDA

The 2017 PDA/

When to Interact with FDA

When to Interact with FDA

Su-Mien Chong speaks about the timing for working with the

Sponsored
Building Your Network and Value to Obtain External Input Prior to Interacting with FDA

Building Your Network and Value to Obtain External Input Prior to Interacting with FDA

Julie Bullock, PharmD, Certara, discusses the limitations the

Teaser Ask the Experts  How to have an effective INTERACT meeting with the FDA

Teaser Ask the Experts How to have an effective INTERACT meeting with the FDA

... have you been seeing um

How to communicate with the FDA

How to communicate with the FDA

In this webinar, hosted by Zuber Lawler, a panel of industry experts discuss how best to

Sponsored
Communication Best Practices – Interacting with Regulatory Project Managers in CDER/ORO

Communication Best Practices – Interacting with Regulatory Project Managers in CDER/ORO

CDER discusses communication best practices when

USFDA How To Behave in Audit Room?Face #regulatory  #inspection #audits #usfda #gmp #pharma #aseptic

USFDA How To Behave in Audit Room?Face #regulatory #inspection #audits #usfda #gmp #pharma #aseptic

USFDA

How to Communicate With the FDA

How to Communicate With the FDA

During this webinar the panel of experts will discuss “How to

FDA Direct - Special Edition of FDA Direct

FDA Direct - Special Edition of FDA Direct

Recapping a year's worth of progress, taking a moment to recognize our amazing staff, and discussing what's next for the

First Interaction with the FDA

First Interaction with the FDA

Su-Mien Chong talks about the first

When a Patient Speaks

When a Patient Speaks

FDA's

FDA Direct: The Power of Real-Time Clinical Trials

FDA Direct: The Power of Real-Time Clinical Trials

Commissioner Makary joins

FDA Patient Listening Sessions: Community Perspectives

FDA Patient Listening Sessions: Community Perspectives

Patients, caregivers and advocates discuss why communities should consider requesting an

Benefits of Meeting with the FDA

Benefits of Meeting with the FDA

Su-Mien Chong talks about what external influences play a factor in getting devices approved or cleared through the

CDER’s Office of Compliance's Use of Remote Interactive Evaluation

CDER’s Office of Compliance's Use of Remote Interactive Evaluation

The

Updates on FDA’s Drug-Drug Interaction Final Guidances

Updates on FDA’s Drug-Drug Interaction Final Guidances

Kellie Reynolds and Xinning Yang from CDER's Office of Clinical Pharmacology discuss two

How To Train Employees for Regulatory/FDA Inspections? @PHARMAVEN #usfda #pharma #training #visual

How To Train Employees for Regulatory/FDA Inspections? @PHARMAVEN #usfda #pharma #training #visual

... #aseptic #pharma #

Opportunities to Engage With the FDA About Qualification During Biomarker Development

Opportunities to Engage With the FDA About Qualification During Biomarker Development

Dr. Kylie Haskins, from

FDA Lecture: Advancing the Science of Patient Input in the Regulatory Settings

FDA Lecture: Advancing the Science of Patient Input in the Regulatory Settings

Advancing the Science of Patient Input in the Regulatory Settings, presented by Martin Ho, Sarah Stothers, Ting-Hsuan Lee, and ...